The application covers a once-weekly autoinjector formulation of the anti-amyloid antibody Leqembi (lecanemab), after a ...

Lexicon did manage to get approval for type 1 diabetes in Europe, but the product was never launched there for commercial ...

CHEERS-AI – or Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence ...

The NHS often relies on professional interpreters and translation services to bridge these gaps, but this comes at a ...

The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to ...

For the wider therapeutic area, the FDA’s response will act as both a cause for concern and a potential way forward. Those ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 ...

Abortion is a major issue this election cycle, and pharma was pulled into it last year when abortion detractors successfully ...

Join the ultimate European gathering of microbiome innovators dedicated to translating groundbreaking research into viable, ...

Under the terms of the deal, MSD (known as Merck & Co in the US and Canada) is paying $30 million upfront for Modifi, with up ...

A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It ...

If approved, the less burdensome version of Leqembi could be used to treat patients at home or in medical facilities, help ...